Quadruple induction therapy including antithymocyte globulin or interleukin-2 receptor antibody or FK 506–based induction therapy after liver transplantation

Saved in:
Bibliographic Details
Published in:Transplantation proceedings 1999-02, Vol.31 (1-2), p.380-380
Main Authors: Lohmann, R, Langrehr, J.M, Klupp, J, Neumann, U, Guckelberger, O, Müller, A.R, Nüssler, N.C, Jonas, S, Lang, M, Settmacher, U, Bechstein, W.-O, Neuhaus, P.J
Format: Article
Language:English
Subjects:
Antibodies, Monoclonal - therapeutic use
Antilymphocyte Serum - therapeutic use
Azathioprine - therapeutic use
Biological and medical sciences
Combined Modality Therapy
Cyclosporine - therapeutic use
Female
Humans
Immunomodulators
Immunosuppression - methods
Immunosuppressive Agents - therapeutic use
Liver Transplantation - immunology
Male
Medical sciences
Pharmacology. Drug treatments
Prednisolone - therapeutic use
Retrospective Studies
Tacrolimus - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0041-1345
1873-2623
DOI:10.1016/S0041-1345(98)01670-4